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To study a passive targeting strategy, via the enhanced permeability and retention
effect following systemic administration of lipid nanocapsules (LNCs) loaded with
ferrociphenol, FcdiOH.
METHODS:
Long chains of polyethylene glycol (DSPE-mPEG2000) were incorporated onto the
surface of LNCs by post-insertion technique. Stealth properties of LNCs were
investigated by in vitro complement consumption and macrophage uptake, and in
vivo pharmacokinetics in healthy rats. Antitumour effect of FcdiOH-loaded LNCs
was evaluated in subcutaneous and intracranial 9L gliosarcoma rat models.
RESULTS:
LNCs and DSPE-mPEG2000-LNCs presented low complement activation and weak
macrophage uptake. DSPE-mPEG2000-LNCs exhibited prolonged half-life and
extended area under the curve in healthy rats. In a subcutaneous gliosarcoma
model, a single intravenous injection of FcdiOH-LNCs (400 μL, 2.4 mg/rat)
considerably inhibited tumour growth when compared to the control. DSPE-
mPEG2000-FcdiOH-LNCs exhibited a strong antitumour effect by nearly
eradicating the tumour by the end of the study. In intracranial gliosarcoma model,
treatment with DSPE-mPEG2000-FcdiOH-LNCs and FcdiOH-LNCs statistically
improved median survival time (28 and 27.5 days, respectively) compared to the
control (25 days).
CONCLUSION:
These results demonstrate the interesting perspectives for the systemic treatment
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